Cargando…
Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function
Severe acute respiratory syndrome virus (SARS-CoV) was the causative agent of the SARS outbreaks in 2002–2003. A safer in vitro system is desirable for conducting research on SARS-CoV and to screen for antiviral drugs against the virus. Based on the infectious cDNA clone of rSARS-CoV-ΔE, in which th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092913/ https://www.ncbi.nlm.nih.gov/pubmed/18619943 http://dx.doi.org/10.1016/j.bbrc.2008.06.129 |